Project Grant HT94252510288
Award Date
6/1/25
Completion Date
5/31/28
Dollars Obligated
$813K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Jacksonville, FL 32224, USA
Similar Awards
This $1,186,914 Project Grant awarded by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports research conducted by Mayo Clinic Jacksonville (A Nonprofit Corporation), doing business as Scott Lynch MD, to resolve the critical role of PINK1 expression and activity in Parkinson's disease pathophysiology and explore therapeutic interventions. The multi-year grant, with a period of performance from June 1, 2025 to May 31, 2028,...
The Department of the Army Medical Command awarded a $400,000 Project Grant to Augusta University Research Institute, Inc. for research under the Military Medical Research and Development program. The grant will fund research from July 1, 2022 to May 30, 2024 to identify mechanisms and treatments for cognitive decline following neurotoxic alpha-synuclein exposure in new Parkinson's disease models. The Military Medical Research and Development program supports biomedical research with the goals...
The U.S. Department of the Army Medical Command awarded a $811,942 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the J. David Gladstone Institutes in San Francisco, California. The grant supports research to investigate genetic variants that may confer susceptibility to toxicant-induced Parkinson's disease, with a focus on understanding the mechanisms by which military-related toxic exposures can lead to adverse health effects. The research will be...
This $1,021,409 federal Project Grant award, issued by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, supports research to investigate maladaptive 5-HT raphe-corticolimbic plasticity underlying the development of nonmotor symptoms in Parkinson's disease. The University of Illinois, as the prime grantee, will conduct this 4-year research project from September 2024 through September 2028. The research aims to transform...
The Cleveland Clinic Foundation will receive $400,000 from the Defense Health Agency under a two-year Project Grant award through the Military Medical Research and Development program (CFDA 12.420). The grant will support research from July 1, 2023 to June 30, 2025 to investigate the role of microglia and the NLRP3 inflammasome in contributing to non-motor deficits associated with Parkinson's disease. The Military Medical Research and Development program aims to transform military and public...
The Department of the Army Medical Command awarded a $1.4 million project grant to The Children's Hospital of Philadelphia Research Institute through the Military Medical Research and Development program. The three-year grant will fund research into the genetic and environmental influences on the pathogenesis of Parkinson's disease by investigating young adult brain and behavioral risk indicators. The Military Medical Research and Development program aims to advance biomedical research that...
The Department of the Army Medical Command awarded a $3.2 million Project Grant to The Trustees of Columbia University in New York, New York to support research titled "NOVEL EXPOSOMICS AND EXTRACELLULAR VESICLE BIOMARKERS TO UNRAVEL GENE - ENVIRONMENT INTERACTIONS AND MECHANISMS OF NEURODEGENERATION IN PARKINSON'S DISEASE." The grant period runs from September 1, 2022 to August 31, 2025. The funding supports research under the Military Medical Research and Development program (CFDA...
The Department of the Army Medical Command awarded a $751,936 Project Grant to the J. David Gladstone Institutes located in San Francisco, California. The grant period runs from September 26, 2022 through September 25, 2025. The grant supports research into the "Impact of Energy Failure on Alpha-Synuclein Spread and Neurodegeneration" under the Military Medical Research and Development program (CFDA 12.420). This program aims to transform military and public health through innovative...
The Department of the Army Medical Command awarded a $1,440,764 Project Grant to The Trustees of Columbia University in New York, New York to support research titled "NOVEL EXPOSOMICS AND EXTRACELLULAR VESICLE BIOMARKERS TO UNRAVEL GENE - ENVIRONMENT INTERACTIONS AND MECHANISMS OF NEURODEGENERATION IN PARKINSON'S DISEASE." The grant is funded under the Military Medical Research and Development program (CFDA 12.420) and aims to transform military and public health care through...
The U.S. Defense Health Agency has awarded a $1,187,875 Project Grant to Mayo Clinic to support the research project "INVESTIGATING MOLECULAR MECHANISMS UNDERLYING THE CILIARY TRAFFICKING OF POLYCYSTINS". This grant, awarded on April 1, 2024 under the Military Medical Research and Development program (CFDA 12.420), will fund research to advance the understanding of the molecular mechanisms involved in the trafficking of polycystins through cellular cilia. The project aims to yield...